ω-3 polyunsaturated fatty acids and concussions: Treatment or not?

Current Sports Medicine Reports

Volumn 10, Issue 4, 2011, Pages 180-185

  Trojian, Thomas H ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGAL OIL; DIZOCILPINE; DOCOSAHEXAENOIC ACID; EDIBLE OIL; FISH OIL; ICOSAPENTAENOIC ACID; KRILL OIL; LINOLENIC ACID; MALONALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CONCUSSION; BRAIN INJURY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; FLUID PERCUSSION INJURY; HUMAN; NERVE FIBER; NEUROPROTECTION; NONHUMAN; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

ANIMALS; ATHLETIC INJURIES; BRAIN CONCUSSION; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-3; HUMANS; RATS; UNITED STATES;

EID: 82955165752     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e31822458d5     Document Type: Article

References (34)

1. Bailes J, Mills J. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma. 2010; 27:1617-24.
2. Bailes J, Mills J, Hadley K. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury? Neurosurgery. 2011 Jan 5. [Epub ahead of print].
3. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am. J. Cardiol. 2007; 99:35-43C.
4. Bazan NG. Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005; 15:159-66. (Pubitemid 40546172)
5. Bazan NG. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell. Mol. Neurobiol. 2006; 26:901-13.
6. Brenna JT, Salem N, Jr, Sinclair AJ, et al. Alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids. 2009; 80:85-91.
7. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann. Pharmacother. 2004; 38:50-2.
8. Curia G, Longo D, Biagini G, et al. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods. 2008; 172:143-57.
9. Ferrari D, Cysneiros RM, Scorza CA, et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 2008; 13:36-42.
10. Harris WS, Pottala JV, Sands SA, et al. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am. J. Clin. Nutr. 2007; 86:1621-5. (Pubitemid 350232175)
11. Hartweg J, Perera R, Montori V, et al. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2008; CD003205.
12. Huang WL, King VR, Curran OE, et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain. 2007; 130:3004-19. (Pubitemid 350033967)
13. Juturu V. Omega-3 fatty acids and the cardiometabolic syndrome. J. Cardiometab. Syndr. 2008; 3:244-53.
14. King VR, Huang WL, Dyall SC, et al. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006; 26:4672-80. (Pubitemid 44315368)
15. Larson MK, Ashmore JH, Harris KA, et al. Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb. Haemost. 2008; 100:634-41.
16. Malinowski JM, Metka K. Elevation of low-density lipoprotein cholesterol concentration with over-the-counter fish oil supplementation. Ann. Pharmacother. 2007; 41:1296-300. (Pubitemid 47122571)
17. Mark BJ, Beaty AD, Slavin RG. Are fish oil supplements safe in finned fish-allergic patients? Allergy Asthma Proc. 2008; 29:528-9.
18. Ménard C, Patenaude C, Gagné AM, et al. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. J. Neurosci. Res. 2009; 87:876-86.
19. Mills JD, Bailes JE, Sedney CL, et al. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J. Neurosurg. 2011; 114:77-84.
20. Olano-Martin E, Anil E, Caslake MJ, et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis. 2010; 209:104-10.
21. Pilitsis JG, Coplin WM, O'Regan MH, et al. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. Neurosci. Lett. 2003; 349:136-8. (Pubitemid 37297832)
22. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am. J. Cardiol. 2006; 98:3-18i.
23. Ramadan E, Rosa AO, Chang L, et al. Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid. J. Lipid Res. 2010; 51:2334-40.
24. Rapoport S, Igarashi M. Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot. Essent. Fatty Acids. 2009; 80:119-23.
25. Riediger ND, Othman RA, Suh M, et al. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Diet Assoc. 2009; 109: 668-79.
26. Sidhu KS. Health benefits and potential risks related to consumption of fish or fish oil. Regul. Toxicol. Pharmacol. 2003; 38:336-44. (Pubitemid 37414822)
27. Signoretti S, Vagnozzi R, Tavazzi B, et al. Biochemical and neurochemical sequelae following mild traumatic brain injury: Summary of experimental data and clinical implications. Neurosurg. Focus. 2010; 29:E1.
28. Simopoulos AP. Evolutionary aspects of diet: The 6-6/6-3 ratio and the brain. Mol. Neurobiol. 2011.
29. Talahalli RR, Vallikannan B, Sambaiah K, et al. Lower efficacy in the utilization of dietary ALA as compared to preformed EPA + DHA on long chain n-3 PUFA levels in rats. Lipids. 2010; 45:799-808.
30. Vreugdenhil M, Bruehl C, Voskuyl RA, et al. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Natl. Acad. Sci. U. S. A. 1996; 93:12559-63. (Pubitemid 26367183)
31. Watson PD, Joy PS, Nkonde C, et al. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel-versusaspirin + clopidogrel in patients with cardiovascular disease. Am. J. Cardiol. 2009; 104:1052-4.
32. Westcott JY, Murphy RC, Stenmark K. Eicosanoids in human ventricular cerebrospinal fluid following severe brain injury. Prostaglandins. 1987; 34:877-87. (Pubitemid 18057918)
33. Wu A, Ying Z, Gomez-Pinilla F. Dietary 6-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma. 2004; 21: 1457-67. (Pubitemid 39435321)
34. Wu A, Ying Z, Gomez-Pinilla F. Omega-3 PUFA supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma. 2007; 24:1587-95. (Pubitemid 350035841)